These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9817980

  • 1. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
    de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG.
    Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM, Vahrson HW, Freeman DA.
    Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
    [Abstract] [Full Text] [Related]

  • 3. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
    Rose PG, Baker S, Fournier L, Nelson BE, Hunter RE.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
    [Abstract] [Full Text] [Related]

  • 4. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH.
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [Abstract] [Full Text] [Related]

  • 5. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
    Meier W, Eiermann W, Stieber P, Schneider A, Fateh-Moghadam A, Hepp H.
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
    [Abstract] [Full Text] [Related]

  • 6. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 7. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
    Hong JH, Tsai CS, Chang JT, Wang CC, Lai CH, Lee SP, Tseng CJ, Chang TC, Tang SG.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):823-30. PubMed ID: 9652844
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, Aalders JG.
    J Clin Oncol; 1996 Jan 01; 14(1):111-8. PubMed ID: 8558185
    [Abstract] [Full Text] [Related]

  • 10. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I, Nakayama H, Okamoto N, Kitamura T, Inoue T.
    Int J Gynecol Cancer; 2006 Jan 01; 16(3):1094-100. PubMed ID: 16803491
    [Abstract] [Full Text] [Related]

  • 11. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 01; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 12. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M, Sakuragi N, Okamoto K, Todo Y, Minobe S, Nomura E, Negishi H, Oikawa M, Yamamoto R, Fujimoto S.
    Acta Obstet Gynecol Scand; 2002 May 01; 81(5):451-7. PubMed ID: 12027820
    [Abstract] [Full Text] [Related]

  • 13. Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix.
    Ferdeghini M, Gadducci A, Annicchiarico C, Prontera C, Malagnino G, Castellani C, Facchini V, Bianchi R.
    Anticancer Res; 1993 May 01; 13(5C):1841-4. PubMed ID: 7505543
    [Abstract] [Full Text] [Related]

  • 14. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
    Scambia G, Benedetti Panici P, Foti E, Amoroso M, Salerno G, Ferrandina G, Battaglia F, Greggi S, De Gaetano A, Puglia G.
    J Clin Oncol; 1994 Nov 01; 12(11):2309-16. PubMed ID: 7964945
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A, Wojcieszek A, Mrochem J, Walaszek-Gruszka A, Deja R, Masłyk B, Bartnik W, Sodowski K.
    Ginekol Pol; 2009 May 01; 80(5):361-6. PubMed ID: 19548456
    [Abstract] [Full Text] [Related]

  • 17. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H, van der Zee AG.
    J Clin Oncol; 2001 Oct 01; 19(19):3960-6. PubMed ID: 11579117
    [Abstract] [Full Text] [Related]

  • 18. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ.
    Int J Gynecol Cancer; 2017 Jun 01; 27(5):994-1000. PubMed ID: 28498239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.